Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
TIL
Stock Latest News
Company Announcements
Instil Bio Faces Heightened Cybersecurity Threats as Data Breach Risks Jeopardize Clinical Trials and Long-Term Strategy
16d ago
TIL
Premium
Pre-Earnings
Instil Bio, Inc. (TIL) Q4 Earnings Cheat Sheet
1M ago
TIL
Premium
The Fly
Instil Bio downgraded to Neutral from Buy at H.C. Wainwright
3M ago
TIL
Premium
Company Announcements
Instil Bio Ends Key Oncology Licensing Agreement with ImmuneOnco
3M ago
8K
TIL
Premium
The Fly
Baird downgrades Instil Bio on discontinuation of AXN-2510
3M ago
TIL
Premium
The Fly
Instil Bio downgraded to Neutral from Outperform at Baird
3M ago
TIL
Premium
The Fly
Instil Bio’s Axion discontinues clinical development of AXN-2510
3M ago
TIL
Premium
The Fly
Instil Bio reports Q3 EPS ($1.75) vs ($2.55) last year
5M ago
TIL
Premium
Company Announcements
Instil Bio’s AXN-2510 Study: A Promising Step in Cancer Treatment
6M ago
TIL
Premium
The Fly
Citizens JMP healthcare analysts hold an analyst/industry conference call
6M ago
TIL
CBIO
Premium
Ratings
Instil Bio’s AXN-2510: Promising Data and Valuation Gap Justify Buy Rating
7M ago
TIL
Premium
The Fly
Instil Bio announces ImmuneOnco presentation of ‘2510 monotherapy data
7M ago
TIL
Premium
Ratings
Instil Bio’s Promising Outlook: Buy Rating Supported by Successful Trials and Market Potential
8M ago
TIL
Premium
Ratings
Instil Bio Receives Buy Rating Amid Promising Trial Data and Strong Financial Outlook
8M ago
TIL
Premium
Company Announcements
Instil Bio Reports Promising Phase 2 Study Results
9M ago
8K
TIL
Premium
The Fly
Instil Bio: ImmuneOnco reports results from Phase 2 study of IMM2510/AXN-2510
9M ago
TIL
Premium
The Fly
Instil Bio announces FDA clearance of IND application for AXN-2510
10M ago
TIL
Premium
The Fly
Instil Bio adds Maraganore to the Board of Directors of Axion Bio
10M ago
TIL
Premium
Ratings
Instil Bio Positioned as a Promising Player in the PD-1/L1 x VEGF Market with Strong Buy Recommendation
10M ago
TIL
Premium
The Fly
Instil Bio appoints Jamie Freedman as CMO
11M ago
TIL
Premium
Company Announcements
Instil Bio Elects Director and Ratifies Auditor
11M ago
8K
TIL
Premium
Company Announcements
Instil Bio Advances Phase 2 Trial in China
11M ago
8K
TIL
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
